Flag of the European Union EU Clinical Trials Register Help

Clinical trials for II

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44380   clinical trials with a EudraCT protocol, of which   7392   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    11,931 result(s) found for: II. Displaying page 91 of 597.
    «« First « Previous 87  88  89  90  91  92  93  94  95  Next» Last»»
    EudraCT Number: 2019-001342-18 Sponsor Protocol Number: IB-0319-001 Start Date*: 2019-08-19
    Sponsor Name:Instituto Bernabeu
    Full Title: CONVENTIONAL STIMULATION IN FOLICULAR PHASE VS. STIMULATION IN LUTEA PHASE IN PATIENTS WITH SUBOPTIMA RESPONSE. RANDOMIZED CLINICAL TRIAL. SUBLUTEAL STUDY
    Medical condition: Suboptimal response of ovarian stimulation
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-013133-22 Sponsor Protocol Number: RGHT 000669 Start Date*: 2009-07-31
    Sponsor Name:Belfast Health & Social Care Trust
    Full Title: Comparison of the effects of single shot or continuous popliteal nerve block on postoperative outcome measures in patients undergoing operative repair of ankle fracture.
    Medical condition: POSTOPERATIVE ANALGESIA AFTER OPERATIVE REPAIR OF ANKLE FRACTURE
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-004720-37 Sponsor Protocol Number: Voluven_v1.0fr Start Date*: 2006-12-11
    Sponsor Name:CUB Hôpital Erasme, Department of Anesthesiology
    Full Title: Effect of Voluven on postoperative morbidity after gynaecological surgery
    Medical condition: Healthy female patients (American Society of Anaesthesiologists score I or II) programmed for elective gynaecological surgery and at least 18 years old
    Disease: Version SOC Term Classification Code Term Level
    8.1 10054182 Perioperative nausea and vomiting prophylaxis LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2011-001398-19 Sponsor Protocol Number: Exposition-DCS Start Date*: 2011-06-27
    Sponsor Name:Charité Universitätsmedizin Berlin
    Full Title: D-cycloserine augmented exposure therapy in patients with agoraphobia
    Medical condition: agarophobia with or without panic disorder
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-001949-15 Sponsor Protocol Number: AK 02 Start Date*: 2005-01-14
    Sponsor Name:photonamic GmbH & Co. KG
    Full Title: PD P 506 A applied for 0.5, 1, 2 or 4 hours in combination with red light for photodynamic therapy of mild to moderate actinic keratosis
    Medical condition: Actinic keratosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-003555-13 Sponsor Protocol Number: AK 03 Start Date*: 2006-03-10
    Sponsor Name:photonamic GmbH & Co. KG
    Full Title: PD P 506 A or its placebo in combination with red light for photodynamic therapy of mild to moderate actinic keratosis
    Medical condition: Actinic keratosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-003556-36 Sponsor Protocol Number: AK 04 Start Date*: 2006-03-10
    Sponsor Name:photonamic GmbH & Co. KG
    Full Title: Photodynamic Therapy with PD P 506 A or its placebo compared with cryosurgery for the treatment of mild to moderate actinic keratosis
    Medical condition: Actinic Keratosis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2019-003032-23 Sponsor Protocol Number: AADC-010 Start Date*: 2019-10-09
    Sponsor Name:National Taiwan University Hospital
    Full Title: A Phase I/II Clinical Trial for Treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC
    Medical condition: Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
    Disease:
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2019-003072-39 Sponsor Protocol Number: NTUH-AADC-011 Start Date*: 2019-10-09
    Sponsor Name:National Taiwan University Hospital
    Full Title: A Clinical Trial for Treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC - An Expansion
    Medical condition: Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
    Disease:
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2021-005511-32 Sponsor Protocol Number: XEOLAS Start Date*: 2022-09-12
    Sponsor Name:Xeolas Pharmaceuticals Ltd.
    Full Title: A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Study to confirm the Efficacy and Safety of “Effects of topical Alendronic Acid on alveolar bone remodeling af...
    Medical condition: Healthy patients periodontal disease, that qualify for oral surgery of the alveolar bone(ASA I and II)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-002236-14 Sponsor Protocol Number: BI1160.206 Start Date*: 2015-10-28
    Sponsor Name:University Hospital Ulm
    Full Title: Phenprocoumon versus Dabigatran in subjects with atrial fibrillation and left atrial thrombus - a prospective, randomized, controlled, open-label one year follow-up pilot study
    Medical condition: left atrial thrombus
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2021-003683-28 Sponsor Protocol Number: SI003-001 Start Date*: 2022-07-28
    Sponsor Name:SelectImmune Pharma AB
    Full Title: Kineret for the treatment of Bladder Pain Syndrome (BPS). Randomized, double-blind, cross-over, phase II trial.
    Medical condition: Patients diagnosed with Bladder Pain Syndrome (BPS)
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-023830-22 Sponsor Protocol Number: AAG-G-H-1102 Start Date*: 2012-05-23
    Sponsor Name:TETEC AG
    Full Title: NDisc Study: A Prospective Randomized Multicentre Phase I / II Clinical Trial to Evaluate Safety and Efficacy of NOVOCART® Disc plus Autologous Disc Chondrocyte Transplantation (ADCT) in the Treatm...
    Medical condition: The subject has a disc herniation with back and /or leg pain (radicular pain) and an identification for sequestrectomy according to the guidelines of DGNC and DGOOC.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004859 10022634 Intervertebral disc disorders LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed) AT (Completed)
    Trial results: View results
    EudraCT Number: 2018-002170-52 Sponsor Protocol Number: 66242 Start Date*: 2019-03-04
    Sponsor Name:VU University Medical Center (VUmc)
    Full Title: TrimetaziDine as a Performance-enhancING drug in Heart Failure with Preserved Ejection Fraction
    Medical condition: Heart failure with preserved ejection fraction (HFpEF)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2019-004010-34 Sponsor Protocol Number: ClaTBI/2019 Start Date*: 2020-05-18
    Sponsor Name:Narodowy Instytut Onkologii im. M. Skłodowskiej-Curie – Państwowy Instytut Badawczy, Oddział w Gliwicach
    Full Title: Assessment of tolerance and spread of the whole body at myeloablative doses in association with cladribine before allogeneic hematopoietic cell transplantation in patients with acute myeloid leukem...
    Medical condition: Accute myeloid leukemia
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004864 10028557 Myeloid leukemia, acute LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: PL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2013-001710-15 Sponsor Protocol Number: GINECO-BR110 Start Date*: 2013-07-19
    Sponsor Name:ARCAGY-GINECO
    Full Title: Phase II study in patient in first line for HER - metastasis breast cancer treated with eribulin and bevacizumab
    Medical condition: Patient with breast adenocarcinoma
    Disease:
    Population Age: Elderly Gender: Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2020-000255-12 Sponsor Protocol Number: D5676C00001 Start Date*: 2020-09-02
    Sponsor Name:AstraZeneca AB
    Full Title: A Phase 2b, Multicentre, Randomised, Double-blind, Placebo controlled, and Open-label Comparator Study of Cotadutide in Participants Who Have Chronic Kidney Disease with Type 2 Diabetes Mellitus
    Medical condition: Chronic Kidney Disease with Type 2 Diabetes Mellitus
    Disease: Version SOC Term Classification Code Term Level
    21.1 10038359 - Renal and urinary disorders 10064848 Chronic kidney disease PT
    21.1 10027433 - Metabolism and nutrition disorders 10067585 Type 2 diabetes mellitus PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-003168-37 Sponsor Protocol Number: Thllo Start Date*: 2019-05-13
    Sponsor Name:University Tuebingen
    Full Title: Therapeutic Iloprost for the treatment of Acute Respiratory Distress Syndrome (ARDS) (the ThIlo-Trial): a prospective, randomized, multicenter phase II study
    Medical condition: Acute respiratory distress syndrome requiring mechanical ventilation
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2021-002247-30 Sponsor Protocol Number: RC31/21/0217 Start Date*: 2021-09-24
    Sponsor Name:CHU TOULOUSE
    Full Title: Evaluation of Amoxicillin diffusion in breast milk according to a population pharmacokinetic approach.
    Medical condition: Breastfeeding
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-003226-16 Sponsor Protocol Number: BP-404 Start Date*: 2017-02-03
    Sponsor Name:Bellicum Pharmaceuticals, Inc.
    Full Title: Follow-up of phase I/II study of CaspaCide T cells from an HLA-partially matched family donor after negative selection of TCR αβ+ T cells in pediatric patients affected by hematological disorders
    Medical condition: Hematological disorders (ALL;AML;Non-Hodgkin lymphoma;Myelodysplastic syndromes;Congenital immune deficiencies;Severe aplastic anemia;Fanconi anemia; Osteopetrosis;Selected cases of hemoglobinopath...
    Disease: Version SOC Term Classification Code Term Level
    19.0 10005329 - Blood and lymphatic system disorders 10018849 Haematological disorders NEC HLGT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 87  88  89  90  91  92  93  94  95  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue Feb 10 13:08:04 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA